Press Releases

Indica Labs and Hamamatsu Photonics K.K. Announce Collaboration to Provide Optimized Integrated Digital Pathology Workflows

Indica Labs and Hamamatsu Photonics K.K. have announced an agreement to maintain long-term interoperability between Indica Lab’s HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.

Quotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility

Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility in Alnwick, UK.

BioIVT Opens New Blood Donor Center in Glasgow, Scotland

Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe.

Bora Pharmaceutical makes strategic appointment to strengthen global manufacturing capabilities.

Huateng Pharma Develops A novel chemiluminescent Substrate APS-5

TransCelerate BioPharma Appoints Janice Chang as New CEO

CD Formulation Strengthens Its Role as a CRO Company for Pharmaceuticals

Combining robust expertise and years of experience, the US-based company CD Formulation further strengthens its role as a contract service provider for pharmaceutical companies in a recent statement.

Samsung Biologics unlocks additional capacity for production at its newest Plant 4

Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program

Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing accelerator, today announced an update on the development of Oxilio’s OXL001 product.

Sharp Adds New Talent with Clinical Leadership Appointments

Sharp, a leading provider of pharmaceutical packaging and clinical services, has strengthened its clinical leadership team with the appointment of Robert Feltz as Director, Analytical and Formulation Services and Michael MacNeir as Vice President, Global Business Development.

High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Healthcare Products

BOC Sciences is able to provide clients with high-standard fermented raw materials that satisfy the quality attributes of finished healthcare products.

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials

RBQM market leader, CluePoints, marks its tenth anniversary as ICH E6 (R3) looks set to mandate the company’s data-driven approach across all clinical trials Risk-Based Quality Management: A front row seat to a decade of transformation

BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications

BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.

BOC Sciences Honored To Assist in the Antibody Research With High-Quality Chemicals

BOC Sciences' chemical products have been applied in a wide range of research projects and helped achieve groundbreaking breakthroughs.

BOC Sciences Reports Its Antibody Modification and Conjugation Technologies in Detail

The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.

BOC Sciences Declares the Availability of 10,000 Impurities, All in Stock!

BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate delivery.

MicrobioSeq Announces the Launch of the Phage Whole-Genome Sequencing Service

CD Genomics RNA-Solutions Platform Now Provides Whole Transcriptome Sequencing Service

CD Formulation Plays a Role in Developing Drug Delivery Systems

Alfa Chemistry Announces the Release of Extracted Peptides